Omega-3-rich fish oil could become a promising tool against non-obese type 2 diabetes by targeting inflammation and insulin resistance, according to new research. A Brazilian team working with a well-established animal model of the disease found that fish oil supplementation significantly improved blood sugar control in diabetic rats.
The study, funded by FAPESP and published in Nutrients, used Goto-Kakizaki rats, which develop type 2 diabetes without becoming obese. After eight weeks of treatment with fish oil, the animals showed lower insulin resistance, reduced inflammatory markers, and healthier lipid profiles, including improvements in total cholesterol, LDL cholesterol, and triglycerides.
Why Non-Obese Diabetes Deserves Attention
Type 2 diabetes is commonly associated with obesity, but an estimated 10% to 20% of patients are not overweight. In these individuals, the mechanisms driving insulin resistance may differ from those seen in obesity, where enlarged fat tissue releases inflammatory compounds that interfere with normal metabolism.
The researchers focused on this less-studied form of diabetes, where chronic inflammation develops despite the absence of excess body fat. Their goal was to determine whether omega-3 fatty acids could improve insulin sensitivity by influencing the immune system.
Previous work by the same research group found that non-obese diabetic rats developed signs of chronic inflammation very early in life. Markers associated with regulatory immune cells were already reduced shortly after weaning, suggesting that immune dysfunction may be involved from the earliest stages of the disease.
How Omega-3s Altered Immune Activity
In the study, rats received fish oil three times per week at a dose of 2 grams per kilogram of body weight, providing high levels of the omega-3 fatty acids EPA and DHA.
After eight weeks, researchers observed significant changes in immune cell activity. Lymphocytes shifted away from a pro-inflammatory state toward a more balanced and regulatory profile.
Specifically, levels of inflammatory Th1 and Th17 cells declined, while regulatory T-cells, which help control excessive immune responses, increased. These immune changes were accompanied by better insulin sensitivity and improved blood glucose regulation.
The findings suggest that inflammation may play a major role in insulin resistance even when obesity is not present. By reducing inflammatory activity, omega-3 fatty acids may help restore the body’s ability to respond properly to insulin.
Human Studies Offer Encouraging Clues
Since the publication of the Nutrients study, additional human research has provided further insight into the metabolic effects of fish oil.
A 2025 double-blind randomized controlled trial published in Food & Function followed healthy middle-aged and older adults who took fish oil supplements for 12 weeks. Participants experienced dose-dependent increases in blood EPA and DHA levels.
Researchers also reported reductions in fasting insulin levels and HOMA-IR, a commonly used measure of insulin resistance. Fasting glucose tended to decline, while several blood lipid markers improved, suggesting potential benefits even before diabetes develops.
Another study published in Nutrition & Diabetes in 2024 analyzed data from 161 people with type 2 diabetes. Researchers found a dose-dependent relationship between omega-3 status and HbA1c, a marker of long-term blood sugar control. The authors concluded that more personalized approaches to omega-3 supplementation may be needed in diabetes management.
More Research Is Still Needed
Despite these promising findings, experts caution against viewing fish oil as a proven treatment for diabetes.
Much of the strongest mechanistic evidence still comes from animal studies, and human trials have produced mixed results, particularly among individuals already living with type 2 diabetes.
The Brazilian researchers emphasize that larger clinical trials are needed to determine the most effective doses, formulations, and patient groups. They also stress that fish oil should be considered a potential complement to established treatments rather than a replacement for lifestyle changes or prescribed medications.
A Growing Focus On Inflammation
The study adds to a growing body of evidence suggesting that type 2 diabetes is not only a metabolic disorder but also an inflammatory condition.
Researchers increasingly believe that immune system activity plays an important role in shaping insulin resistance across different forms of diabetes. Omega-3 fatty acids may offer one way to modify that inflammatory environment and improve metabolic health.
While more human studies are needed, the findings provide another example of how nutrition and immune function intersect in the development and treatment of chronic disease.
